Soluble VEGF receptor-2 may be a predictive marker of anti-angiogenic therapy with clinically available safe agents

The identification of biomarkers of anti-angiogenic therapy that predict clinical benefit is of vital importance. We previously reported that a combination treatment with clinically available safe agents, specifically angiotensin-converting enzyme inhibitor (ACE-I) and vitamin K (VK), inhibited the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: YOSHIJI, HITOSHI, NOGUCHI, RYUICHI, IKENAKA, YASUHIDE, KAJI, KOSUKE, SHIRAI, YUSAKU, AIHARA, YOSUKE, YAMAO, JUNICHI, TOYOHARA, MASAHISA, MITORO, AKIRA, SAWAI, MASAYOSHI, YOSHIDA, MOTOYUKI, MORIOKA, CHIE, FUJIMOTO, MASAO, UEMURA, MASAHITO, KAWARATANI, HIDETO, TSUJIMOTO, TATSUHIRO, FUKUI, HIROSHI
Format: Artigo
Sprache:Inglês
Veröffentlicht: D.A. Spandidos 2011
Schlagworte:
Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3412527/
https://ncbi.nlm.nih.gov/pubmed/22870131
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2010.196
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge